#COVID-19 vaccine

People with long COVID and those who experienced side effects from mRNA vaccines are seeking Novavax’s protein-based offering.

New flu and COVID vaccines are available for everyone, and RSV vaccines for people 60 and older.

The protein-based vaccine works in a different way than the mRNA vaccines from Moderna and Pfizer-BioNTech.

The technology, developed by Katalin Karikó and Drew Weissman, also holds promise for HIV vaccines and cancer treatment.

A boost in protection is needed to offset the persistent disparities in the toll of COVID between racial and ethnic groups.

The vaccines tend to prevent infection for only a few months, but they offer longer protection against hospitalization and death.

Updated COVID vaccines will be available in some locations this week, with distribution increasing in the coming weeks.

Updated coronavirus vaccine is recommended for all adults and children ages 6 months and older.

People at lower risk may not need an updated booster, but without a CDC recommendation, insurance companies wouldn’t have to cover it.

People ages 6 months and older are eligible for new Moderna and Pfizer-BioNTech boosters targeting XBB.1.5 omicron variant.

Who should get flu, COVID and RSV vaccines—and when?

The confusion about what’s true—and who’s telling the truth—is of critical importance to public health.

Antibodies crossed the placenta, likely conferring some protection for newborns immediately after birth.

The program, launching this fall, will help uninsured people and those whose insurance does not cover free vaccines.

The compromise bill leaves Medicare and Medicaid funding untouched and includes no new work requirements for Medicaid.

For the millions who are more vulnerable to COVID, reliable data remains important for assessing safety.